http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100749222-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
filingDate 2001-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2007-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2007-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-100749222-B1
titleOfInvention Process for the preparation of 6- (4-chlorophenyl) -2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolidin-5-ylacetic acid
abstract The present invention reacts a compound of formula III with oxalyl chloride and the resulting product is treated with hydrazine and alkali metal hydroxides in an aqueous phase at elevated temperature, ether is added to form a three-phase system after the treatment is completed, and the intermediate phase is acidified The present invention relates to a process for preparing the compound of formula (I).n n n <Formula I>n n n n n n n n <Formula III>n n n n n n n n The present invention further relates to polymorphs of compounds of formula (I).n n n Disorders of 6- (4-chlorophenyl) -2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolidin-5-ylacetic acid, polymorph, rheumatoid type
priorityDate 2000-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9532971-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426576149
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12083002
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9945001
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID133021
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420765701
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419514355
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68303
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415740067

Total number of triples: 43.